Latest Breaking News On - Scientific sessions november - Page 1 : vimarsana.com

/PRNewswire/ Vasa Therapeutics, Inc., a preclinical stage company developing first-in-class treatments for cardiovascular indications with limited or no.

United statesPiotr lipinskiPatricia pellicenaBheema paraselliMark herbertHoward schulmanMagdalena krupaDaniel levyChris larsonBenjamin prattArtur plonowskiPrnewswire vasa therapeutics incAmerican heart associationDrug discovery for cardiovascular researchVasa therapeutics incScientific sessions november